JP2005534752A5 - - Google Patents

Download PDF

Info

Publication number
JP2005534752A5
JP2005534752A5 JP2004525093A JP2004525093A JP2005534752A5 JP 2005534752 A5 JP2005534752 A5 JP 2005534752A5 JP 2004525093 A JP2004525093 A JP 2004525093A JP 2004525093 A JP2004525093 A JP 2004525093A JP 2005534752 A5 JP2005534752 A5 JP 2005534752A5
Authority
JP
Japan
Prior art keywords
antibody
antigen
galnac
binding fragment
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004525093A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005534752A (ja
JP4718174B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2003/001156 external-priority patent/WO2004013151A2/en
Publication of JP2005534752A publication Critical patent/JP2005534752A/ja
Publication of JP2005534752A5 publication Critical patent/JP2005534752A5/ja
Application granted granted Critical
Publication of JP4718174B2 publication Critical patent/JP4718174B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

JP2004525093A 2002-08-01 2003-07-30 カンピロバクターグリカンおよびグリコペプチド Expired - Fee Related JP4718174B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39973502P 2002-08-01 2002-08-01
US60/399,735 2002-08-01
PCT/CA2003/001156 WO2004013151A2 (en) 2002-08-01 2003-07-30 Campylobacter glycans and glycopeptides

Publications (3)

Publication Number Publication Date
JP2005534752A JP2005534752A (ja) 2005-11-17
JP2005534752A5 true JP2005534752A5 (enExample) 2006-09-07
JP4718174B2 JP4718174B2 (ja) 2011-07-06

Family

ID=31495764

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004525093A Expired - Fee Related JP4718174B2 (ja) 2002-08-01 2003-07-30 カンピロバクターグリカンおよびグリコペプチド

Country Status (9)

Country Link
US (1) US7598354B2 (enExample)
EP (1) EP1527080B1 (enExample)
JP (1) JP4718174B2 (enExample)
CN (1) CN1671722A (enExample)
AU (1) AU2003254665C1 (enExample)
BR (1) BR0312896A (enExample)
CA (1) CA2494223C (enExample)
ES (1) ES2391525T3 (enExample)
WO (1) WO2004013151A2 (enExample)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7214660B2 (en) * 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
CA2477794C (en) 2002-03-07 2013-08-20 Eidgenoessische Technische Hochschule Zuerich System and method for the production of recombinant glycosylated proteins in a prokaryotic host
AU2002952121A0 (en) * 2002-10-17 2002-10-31 Alchemia Limited Novel carbohydrate based anti-bacterials
SG155777A1 (en) 2003-04-09 2009-10-29 Neose Technologies Inc Glycopegylation methods and proteins/peptides produced by the methods
WO2005012484A2 (en) 2003-07-25 2005-02-10 Neose Technologies, Inc. Antibody-toxin conjugates
US8633157B2 (en) 2003-11-24 2014-01-21 Novo Nordisk A/S Glycopegylated erythropoietin
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
US20080015142A1 (en) * 2003-12-03 2008-01-17 Defrees Shawn Glycopegylated Follicle Stimulating Hormone
US20080300173A1 (en) 2004-07-13 2008-12-04 Defrees Shawn Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1]
HUE026826T2 (en) 2004-10-29 2016-07-28 Ratiopharm Gmbh Modeling and glycopegylation of fibroblast growth factor (FGF)
US9029331B2 (en) 2005-01-10 2015-05-12 Novo Nordisk A/S Glycopegylated granulocyte colony stimulating factor
EP1871795A4 (en) 2005-04-08 2010-03-31 Biogenerix Ag COMPOSITIONS AND METHOD FOR PRODUCING GLYCOSYLATION MUTANTS OF A PROTEASE-RESISTANT HUMAN GROWTH HORMONE
JP5356807B2 (ja) 2005-05-11 2013-12-04 アイトヘネーシシェ テフニーシェ ホフシューレ チューリッヒ 原核細胞由来の組み換えｎ−グリコシル化タンパク質
US20070105755A1 (en) * 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
US20090048440A1 (en) 2005-11-03 2009-02-19 Neose Technologies, Inc. Nucleotide Sugar Purification Using Membranes
US20080248959A1 (en) 2006-07-21 2008-10-09 Neose Technologies, Inc. Glycosylation of peptides via o-linked glycosylation sequences
JP2010505874A (ja) 2006-10-03 2010-02-25 ノヴォ ノルディスク アー／エス ポリペプチドコンジュゲートの精製方法
RS52845B (sr) 2007-04-03 2013-12-31 Biogenerix Ag Postupci tretmana korišćenjem glikopegiliranog g-csf
JP5876649B2 (ja) 2007-06-12 2016-03-02 ラツィオファルム ゲーエムベーハーｒａｔｉｏｐｈａｒｍ ＧｍｂＨ ヌクレオチド糖の改良製造法
US8999668B2 (en) 2008-01-03 2015-04-07 Cornell Research Foundation, Inc. Glycosylated protein expression in prokaryotes
EP2242505A4 (en) * 2008-01-08 2012-03-07 Biogenerix Ag GLYCOCONJUGATION OF POLYPEPTIDES USING OLIGOSACCHARYLTRANSFERASES
HRP20181259T1 (hr) 2008-02-20 2018-10-05 Glaxosmithkline Biologicals S.A. Biokonjugati načinjeni iz rekombinantnih n-glikoziliranih proteina iz prokariotskih stanica
ES2476690T3 (es) 2008-02-27 2014-07-15 Novo Nordisk A/S Moléculas conjugadas del Factor VIII
PL2411503T3 (pl) * 2009-03-27 2018-01-31 Eidgenoessische Technische Hochschule Zuerich Salmonella enterica prezentująca n-glikan z c. jejuni lub jego pochodne
AU2010322454B2 (en) 2009-11-19 2016-05-19 Glaxosmithkline Biologicals S.A. Biosynthetic system that produces immunogenic polysaccharides in prokaryotic cells
JP5925699B2 (ja) * 2010-02-11 2016-05-25 ザ・ガバナーズ・オブ・ザ・ユニバーシティー・オブ・アルバータ Ｎ結合型グリカン化合物
US8841099B2 (en) * 2010-04-20 2014-09-23 National Research Council Of Canada Cell-based production of nonulosonates
ES2844596T3 (es) 2010-05-06 2021-07-22 Glaxosmithkline Biologicals Sa Vacunas de bioconjugados de bacterias grampositivas capsulares
US9308246B2 (en) 2010-05-28 2016-04-12 The United States Of America As Represented By The Secretary Of The Navy Capsule composition for use as immunogen against Campylobacter jejuni
JP6135046B2 (ja) * 2012-04-20 2017-05-31 株式会社島津製作所 糖ペプチドの質量分析法
EP2991675B1 (en) 2013-04-05 2019-07-24 The Governors of the University of Alberta Campylobacter vaccine
EP4205553A1 (en) * 2015-01-26 2023-07-05 DSM Nutritional Products, LLC Oligosaccharide compositions for use animal feed and methods of producing thereof
WO2017117539A1 (en) 2015-12-30 2017-07-06 Northwestern University Cell-free glycoprotein synthesis (cfgps) in prokaryotic cell lysates enriched with components for glycosylation
US10829795B2 (en) 2016-07-14 2020-11-10 Northwestern University Method for rapid in vitro synthesis of glycoproteins via recombinant production of N-glycosylated proteins in prokaryotic cell lysates
US11898187B2 (en) 2017-08-15 2024-02-13 Northwestern University Protein glycosylation sites by rapid expression and characterization of N-glycosyltransferases
WO2019119134A1 (en) * 2017-12-19 2019-06-27 The Governors Of The University Of Alberta Clostridium perfringens surface glycans and uses thereof
US11530432B2 (en) 2018-03-19 2022-12-20 Northwestern University Compositions and methods for rapid in vitro synthesis of bioconjugate vaccines in vitro via production and N-glycosylation of protein carriers in detoxified prokaryotic cell lysates
US11725224B2 (en) 2018-04-16 2023-08-15 Northwestern University Methods for co-activating in vitro non-standard amino acid (nsAA) incorporation and glycosylation in crude cell lysates
WO2020072127A2 (en) 2018-08-03 2020-04-09 Northwestern University On demand, portable, cell-free molecular sensing platform
US12404533B2 (en) 2019-01-11 2025-09-02 Northwestern University Bioconjugate vaccines' synthesis in prokaryotic cell lysates
US12325884B2 (en) 2019-03-04 2025-06-10 Northwestern University Riboswitch-based fluoride sensing in cell-free extract
US12226410B2 (en) 2019-10-18 2025-02-18 Northwestern University Methods for enhancing cellular clearance of pathological molecules via activation of the cellular protein ykt6
US20240287564A1 (en) * 2021-06-07 2024-08-29 The University Of British Columbia Acholetin biopolymers and methods for enzymatic synthesis

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925796A (en) * 1986-03-07 1990-05-15 Massachusetts Institute Of Technology Method for enhancing glycoprotein stability
US5200344A (en) * 1990-11-13 1993-04-06 Blaser Martin J Diagnostic testing for campylobacter jejuni or campylobacter coli infections using novel antigens
WO1995005850A1 (en) * 1993-08-27 1995-03-02 Enteric Research Laboratories, Inc. Campylobacter jejuni antigens, and methods for their production and use
WO1996007753A1 (en) * 1994-09-06 1996-03-14 Bioflexin Ab Amino acid conjugate
US5840547A (en) * 1995-01-05 1998-11-24 Ramot University Authority For Applied Research & Indfustrial Development Ltd. Bioemulsifiers
US6676946B2 (en) * 1997-03-27 2004-01-13 Institut Pasteur Multiple antigen glycopeptide carbohydrate vaccine comprising the same and use thereof
US6699705B2 (en) * 1999-02-01 2004-03-02 National Research Council Of Canada Campylobacter glycosyltransferases for biosynthesis of gangliosides and ganglioside mimics
AU3513500A (en) * 1999-03-05 2000-09-21 Trustees Of Tufts College Emulsan and emulsan analogs immunization formulations and use
US6512014B2 (en) * 2000-12-13 2003-01-28 Ramot University Authority For Applied Research And Industrial Development Limited Compositions containing bioemulsifiers and a method for their preparation
ES2561985T3 (es) * 2001-10-10 2016-03-01 Ratiopharm Gmbh Remodelación y glicoconjugación de anticuerpos
US20030232401A1 (en) * 2002-06-12 2003-12-18 Pugia Michael J. Bacterial test method by glycated label binding
US9084809B2 (en) * 2005-09-21 2015-07-21 The United States Of America As Represented By The Secretary Of The Navy Immunogenic capsule composition for use as a vaccine component against Campylobacter jejuni

Similar Documents

Publication Publication Date Title
JP2005534752A5 (enExample)
CA2494223A1 (en) Campylobacter glycans and glycopeptides
Lee et al. Causative agents and epidemiology of diarrhea in Korean native calves
Werner et al. Antibiotic resistant enterococci—Tales of a drug resistance gene trafficker
Leitner et al. Development of a Staphylococcus aureus vaccine against mastitis in dairy cows. II. Field trial
Zhao et al. Immersion vaccination of Mandarin fish Siniperca chuatsi against infectious spleen and kidney necrosis virus with a SWCNTs-based subunit vaccine
US20090324648A1 (en) Vaccine for edwardsiella disease and streptococcal disease in fish
PH12015501888B1 (en) Novel bacteriophage and antibacterial composition comprising the same
ES2527470T3 (es) Composición farmacéutica que comprende un inhibidor de la bomba de protones y un prebiótico para el tratamiento de lesiones ulcerosas del estómago y el duodeno
CA2257826A1 (en) Helicobacter pylori adhesin binding group antigen
CN102139103B (zh) 半滑舌鳎美人鱼发光杆菌疫苗的制备与使用方法
TWI433651B (zh) 新穎乳酸菌株、含彼之組合物及其用途
JP2006525981A (ja) アリシン
CN101002947B (zh) 一种用于细菌病治疗的靶向药物及其制备方法
Sombe et al. Optimization and Field Trial of an Aeromonas hydrophila Vaccine candidate for motile aeromonads septicemia in farmed Nile tilapia in Tanzania
KR19980081625A (ko) 장관 출혈성 대장균에 의한 감염증의 예방제 및 치료제
CN104388394B (zh) 水貂细小病毒弱毒疫苗株及其在制备水貂细小病毒弱毒疫苗中的用途
Singh et al. Therapeutic management of Bovine Brucellosis in endemically infected dairy cattle herd of native Sahiwal breed.
Tarello et al. Corynebacterium pseudotuberculosis and Corynebacterium renale isolated from two Arabian oryx (Oryx leucoryx)
RU2179846C2 (ru) Средство для профилактики и лечения желудочно-кишечных и респираторных заболеваний телят
KR102003795B1 (ko) 신규한 시가톡신 생성 대장균 특이 박테리오파지 ecoh1 및 이를 포함하는 항균 조성물
RU2429871C1 (ru) Препарат для лечения желудочно-кишечных болезней телят и способ его применения
TW200423956A (en) Adjuvanted bovine vaccines
US10596206B1 (en) Probiotic compositions and methods of use
CN109913391B (zh) 罗非鱼源海豚链球菌弱毒株及应用